Immunizations in Adolescents and Adults with and at-risk for HIV Disease
Jane R. Zucker, MD, MSc
Assistant Commissioner
NYC Department of Health and Mental Hygiene
New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2018. All rights reserved.
Jane R. Zucker received her MD degree from the Mount Sinai School of Medicine and her MSc degree in Epidemiology from the Harvard School of Public Health. She completed her internal medicine residency at Kings County Hospital/SUNY Downstate and her Infectious Diseases fellowship at the Beth Israel, Brigham and Women's Hospital and Dana Farber Cancer Institute program in Boston. Dr. Zucker has served as the Assistant Commissioner for the Bureau of Immunization at the New York City Department of Health and Mental Hygiene since August 2005. She is responsible for policy development, program management and integrity of the NYC Immunization Program. Dr. Zucker’s responsibilities also include development of programs and policies to increase vaccine coverage of adults, adolescents and children citywide, introduce new vaccines and oversight of the Vaccines for Children program (VFC) and the Citywide Immunization Registry (CIR). Under her leadership, vaccination coverage for routinely recommended vaccines, including influenza, have continued to increase among young children, adolescents and adults, while racial disparities have decreased. Further, she has established a strong Adult Immunization program that works to increase vaccination coverage of all recommended vaccines through implementation of evidenced-based strategies.
At the completion of this educational session, learners will:
- Know how the annual influenza prevention efforts provide an opportunity to maximize routine recommended vaccine coverage for general and specific sub-group populations at risk.
- Appreciate the epidemiology of preventable infections in NYC, and the role that immunizations play in reducing their impact.
- Know the current recommendations for vaccines in at-risk adolescent and adult HIV-positives and PrEP candidates, including meningococcal vaccine, HBV vaccine, HAV vaccine, HPV vaccine, etc.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
